Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

Chinese Academy of Medical Sciences & Peking Union Medical College

Status: Completed

Conditions: Esophageal Neoplasms

Treatments: Radiation: definitive radiotherapy or definitive chemoradiotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT05194371

YW2021-92-1

Details and patient eligibility

About

In this study, data of esophageal cancer patients undergoing definitive radiotherapy in 14 institutions from various provinces in China were evaluated to help strengthen confidence in anti-cancer, including rehabilitation, economic burden, and quality of life.

Enrollment: 3,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with esophageal cancer who received definitive radiotherapy (radiotherapy dose ≥50Gy) from 2015 to 2016
2. Age ≥ 18
3. The radiation field included primary esophageal tumor with or without lymph node metastasis

Exclusion criteria

1. Radiotherapy dose < 50Gy
2. Palliative radiotherapy
3. The radiation field are metastatic areas, such as bone, brain, adrenal gland, isolated metastatic lymph nodes, etc

Trial design

3,000 participants in 1 patient group

Definitive (chemo)radiotherapy

Treatment:

Radiation: definitive radiotherapy or definitive chemoradiotherapy